% | $
Quotes you view appear here for quick access.

Celgene Corporation Message Board

  • mjjk1 mjjk1 Mar 11, 2013 12:30 PM Flag

    CELG price target increase to $127

    today price target increase was from Bank of America/Merrill. Can not paste link because it is a paid site. It will most likely be in the yahoo news some time in the future.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • you can find this news at goog finance site,

      • 1 Reply to eb5339
      • Dwight Einhorn, Benzinga Staff Writer March 11, 2013 10:10 AM

        In a report published Monday, Bank of America reiterated its Buy rating on Celgene Corporation (NASDAQ: CELG [FREE Stock Trend Analysis]), and raised its price target from $113.00 to $127.00.

        Bank of America noted, “We are reiterating our Buy rating on CELG and increasing our PO from $113 to $127 following results of a commissioned statistical analysis we completed for CELG's ongoing Revlimid study MM020 in newly diagnosed myeloma. As a reminder, we believe that positive data for MM020 are critical for CELG's prospects of expanding the Revlimid indication from relapsed/refractory to the broader newly diagnosed setting. Based on our findings, we are reversing our bearish stance on the study outcome, and believe there remains an additional 15-20% potential upside to the shares following the recent run up. We see balanced downside risks on a negative outcome.”

        Celgene Corporation closed on Friday at $111.36.

106.43+0.65(+0.61%)May 27 4:00 PMEDT